Next, to investigate the expression pattern and clinicopathological implications of SFN, GORASP2 and ZYG11A, we performed IHC using 171 cases of lung adenocarcinoma (Figure 3D–3I). Here, GORASP2 is linked to lung adenocarcinoma.